Recombinant Human Growth Hormone for Injection (Zhongshan Sinobioway Hygene Biomedicine)

注射用重组人生长激素(中山未名海济生物医药)

Report date: 2022/01/14 13:23:58

Base Information

Drug NameRecombinant Human Growth Hormone for Injection (Zhongshan Sinobioway Hygene Biomedicine)
Drug Alias Name海之元Sinotropin
ClassificationBiologics > Protein drugs > Recombinant protein > Recombinant hormone
Mechanisms of ActionGrowth hormone receptor agonists
TargetsGrowth hormone receptor
Therapy Area/IndicationsGrowth hormone deficiencyGrowth Disorders
Global Approved IndicationsGrowth hormone deficiencyGrowth Disorders
Approved Indications in ChinaGrowth hormone deficiencyGrowth Disorders
Original Approved Country/TerritoryMainland China
Original Approved Date2005/03/23
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
China Registration ClassN/A

Develop Information

Inactive CompaniesN/A
Active IndicationsGrowth hormone deficiencyGrowth Disorders
Inactive IndicationsN/A

Other Information

ATC CodeH01AC01
Related LinksN/A